| 产品描述: | Werner syndrome RecQ helicase-IN-3 is a potent and orally active werner syndrome recQ helicase (WRN) inhibitor with an IC50 value of 0.06 µM. Werner syndrome RecQ helicase-IN-3 shows antiproliferative activity. Werner syndrome RecQ helicase-IN-3 shows anticancer activity[1]. |
| 体外研究: |
Werner syndrome RecQ helicase-IN-3 (120 mg/kg; daily for 22 days) 在小鼠体内显示出抗癌活性[1]。 |
| 体内研究: |
Werner syndrome RecQ helicase-IN-3 (example 96) (0-10 µM; 8-20 days) 显示抗增殖活性,对 SW48,DLD1 WRN-KO 细胞的 GI50s 值分别为 0.06,>10 µM[1]。 |
| 参考文献: |
1. Vincent Bordas, et al. Triazolo-pyrimidine analogues for treating diseases connected to the inhibiton of werner syndrome recq helicase (wrn). WO2022249060A1. |
| 保存条件: |
-80°C 6个月;-20°C 1个月 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.455 ml |
7.277 ml |
14.555 ml |
| 5 mM |
0.291 ml |
1.455 ml |
2.911 ml |
| 10 mM |
0.146 ml |
0.728 ml |
1.455 ml |
| 50 mM |
0.029 ml |
0.146 ml |
0.291 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |